HIQ Stock Overview
HitIQ Limited engages in development and commercialization of concussion management technology in Australia.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
HITIQ Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.028 |
| 52 Week High | AU$0.13 |
| 52 Week Low | AU$0.023 |
| Beta | 0 |
| 1 Month Change | 7.69% |
| 3 Month Change | -31.71% |
| 1 Year Change | -77.60% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| HIQ | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | -3.4% | 5.0% | 0.6% |
| 1Y | -77.6% | 26.5% | 5.4% |
Return vs Industry: HIQ underperformed the Australian Healthcare Services industry which returned 26.5% over the past year.
Return vs Market: HIQ underperformed the Australian Market which returned 5.4% over the past year.
Price Volatility
| HIQ volatility | |
|---|---|
| HIQ Average Weekly Movement | 35.1% |
| Healthcare Services Industry Average Movement | 9.8% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 15.9% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: HIQ is more volatile than 90% of Australian stocks over the past 3 months, typically moving +/- 35% a week.
Volatility Over Time: HIQ's weekly volatility has increased from 23% to 35% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 25 | Mike Vegar | https://hitiq.com |
HitIQ Limited engages in development and commercialization of concussion management technology in Australia. Its Nexus software provides comprehensive head impact data and analysis to make informed decisions to improve the quality of care for athletes. It also offers CoVR, a virtual reality based cognitive and oculomotor assessment platform, which identifies impairments across domains, such as hand-eye coordination, memory, and decision making; and CSX that provides an easy to use, sideline concussion assessment tool, which produces a digital record that can be shared with medical professionals, family, and organizations to take coordinated athlete care.
HITIQ Limited Fundamentals Summary
| HIQ fundamental statistics | |
|---|---|
| Market Cap | AU$7.47m |
| Earnings (TTM) | -AU$6.95m |
| Revenue (TTM) | AU$1.64m |
4.5x
P/S Ratio-1.1x
P/E RatioIs HIQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HIQ income statement (TTM) | |
|---|---|
| Revenue | AU$1.64m |
| Cost of Revenue | AU$4.29m |
| Gross Profit | -AU$2.64m |
| Other Expenses | AU$4.30m |
| Earnings | -AU$6.95m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.026 |
| Gross Margin | -160.78% |
| Net Profit Margin | -422.57% |
| Debt/Equity Ratio | 184.1% |
How did HIQ perform over the long term?
See historical performance and comparison